Pardeep Nijhawan, Chief Executive Officer, 10% Owner at Edesa Biotech, Inc. (EDSA), bought 3,000 shares at $2.28 ($6K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market purchase of $6k EDSA by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 2,000 | $4K | 63.7% |
| 2 | $2.28 | 1,000 | $2K | 36.3% |
| Total | $2.09 avg | 3,000 | $6K | 100% |
| Filing → |
| EDSA | BUY | 2026-03-05 | $43K | — | Filing → |
| EDSA | BUY | 2026-03-04 | $36K | — | Filing → |
| EDSA | BUY | 2026-03-02 | $198K | — | Filing → |